MENU
+Compare
LFCR
Stock ticker: NASDAQ
AS OF
Dec 12 closing price
Price
$7.79
Change
-$0.02 (-0.26%)
Capitalization
291.86M

LFCR Lifecore Biomedical Forecast, Technical & Fundamental Analysis

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges... Show more

LFCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for LFCR with price predictions
Dec 11, 2025

LFCR in upward trend: 10-day moving average moved above 50-day moving average on November 12, 2025

The 10-day moving average for LFCR crossed bullishly above the 50-day moving average on November 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where LFCR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

LFCR moved above its 50-day moving average on November 10, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LFCR advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 174 cases where LFCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LFCR moved out of overbought territory on November 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LFCR as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LFCR turned negative on December 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LFCR broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LFCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LFCR's P/B Ratio (192.308) is slightly higher than the industry average of (19.578). P/E Ratio (51.231) is within average values for comparable stocks, (73.186). LFCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.942). LFCR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (2.105) is also within normal values, averaging (64.206).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
LFCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

LFCR is expected to report earnings to fall 62.07% to -10 cents per share on January 01

Lifecore Biomedical LFCR Stock Earnings Reports
Q4'25
Est.
$-0.11
Q3'25
Beat
by $0.03
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.33
Q4'24
Beat
by $0.02
The last earnings report on November 06 showed earnings per share of -28 cents, beating the estimate of -31 cents. With 133.31K shares outstanding, the current market capitalization sits at 291.86M.
A.I. Advisor
published General Information

General Information

a manufacturer of polymer products for food and agricultural products, medical devices and licensed partner applications

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Industrial Specialties
Address
3515 Lyman Boulevard
Phone
+1 952 368-4300
Employees
459
Web
https://www.lifecore.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBNKF17.87N/A
N/A
Nordea Bank Abp
FPRUY39.23N/A
N/A
Fraport AG
VBVBF16.90N/A
N/A
VERBIO SE
SAVNF0.05N/A
N/A
SAVANNAH RESOURCES PLC
FALC1.73-0.05
-2.81%
FalconStor Software, Inc.

LFCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+2.36%
NBIX - LFCR
36%
Loosely correlated
-0.57%
AMRX - LFCR
32%
Poorly correlated
+0.33%
ZTS - LFCR
31%
Poorly correlated
-0.35%
SHPH - LFCR
31%
Poorly correlated
-3.24%
KMDA - LFCR
28%
Poorly correlated
-0.14%
More

Groups containing LFCR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+2.36%
Pharmaceuticals: Generic
industry (213 stocks)
33%
Poorly correlated
+1.09%